Prostatis Group’s Invesco S&P SmallCap Momentum ETF XSMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.84M Buy
76,782
+310
+0.4% +$23.9K 1.49% 11
2025
Q4
$5.51M Buy
76,472
+9,947
+15% +$724K 1.31% 15
2025
Q3
$4.89M Buy
66,525
+12,149
+22% +$859K 1.23% 18
2025
Q2
$3.7M Buy
54,376
+3,140
+6% +$200K 1.06% 24
2025
Q1
$3.22M Buy
51,236
+14,132
+38% +$930K 1.01% 26
2024
Q4
$2.45M Buy
+37,104
New +$2.55M 0.72% 36

Other funds holding XSMO

Prostatis Group's XSMO Position: Q1 2026 in Review

Prostatis Group increased its Invesco S&P SmallCap Momentum ETF (XSMO) stake by 0.41% in Q1 2026, buying an estimated $23.9K and bringing the position to 76,782 shares worth $5.84M. The position accounts for 1.49% of the portfolio, ranked #11.

Prostatis Group first reported a position in XSMO in Q4 2024 and has held it in 6 quarters since. 295 funds tracked by Wall St. Rank hold XSMO as of Q1 2026.

  • Prostatis Group held 76,782 shares of Invesco S&P SmallCap Momentum ETF worth $5.84M as of Q1 2026.
  • Prostatis Group bought 310 Invesco S&P SmallCap Momentum ETF shares in Q1 2026, an estimated $23.9K.
  • Invesco S&P SmallCap Momentum ETF made up 1.49% of Prostatis Group's portfolio in Q1 2026, its #11 holding.
  • Prostatis Group first reported a position in Invesco S&P SmallCap Momentum ETF in Q4 2024 and has held it in 6 quarters since.
  • 295 funds tracked by Wall St. Rank held Invesco S&P SmallCap Momentum ETF as of Q1 2026.

Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.